UNSPSC 51282320: Erythromycin gluceptate

This classification denotes a macrolide antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2AY21R0U64. European Medicines Agency schedules Erythromycin gluceptate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01943MIG. Erythromycin glucoheptonate generally arises in the molecular formula C37H67NO13.C7H14O8. The term 'erythromycin glucoheptonate' is a U.S. Pharmacopeial Convention designation.

UNSPSC 51282320 Erythromycin gluceptate is a Commodity code that nominally describes a specific pharmaceutical product, but recent state and local opportunities tagged under this code show no procurement activity for erythromycin gluceptate itself. Instead, the opportunities solicited under the code span naloxone and drug deactivation systems, emergency medical supplies for fire rescue operations, generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing, and direct-to-manufacturer prescription program vendor capabilities. This mismatch between the code's nominal scope and actual recent activity suggests the code sees limited relevant procurement volume or that issuing bodies are using the code as a catch-all for pharmaceutical procurement rather than for erythromycin gluceptate specifically. The mix of issuing bodies includes county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health agencies (Texas Health and Human Services Commission), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple state and local participants across multiple states including Oregon).

Geographic activity centers on Florida and Minnesota, with emerging activity in Texas and multi-state cooperative purchasing reaching across participating jurisdictions. Representative recent opportunities include Seminole County's IFB60459723LAS (posted June 30, 2026; response due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually; the City of Tampa's IFB 26P00145 (posted March 25, 2026; response due March 13, 2026) for 169 line items of emergency medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a sheltered-market set-aside for certified Small Local Business Enterprises; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026; response due March 26, 2026) for generic multi-source pharmaceuticals and OTC products, with awards effective July 1, 2026. The Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026) sought market intelligence on direct-to-manufacturer prescription programs. Vendors pursuing this code should verify that opportunities are tagged correctly and assess whether the pharmaceutical commodity families actually being solicited align with their product lines.